Exploiting therapeutic vulnerabilities to identify new treatments for high-risk SHH medulloblastoma
Exploiting therapeutic vulnerabilities to identify new treatments for high-risk SHH medulloblastoma
批准号:
470134
负责人:
Ramaswamy Vijay
金额:
$93.63万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
未结题
起止时间:
2022-09-01 至 2027-09-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Medulloblastoma is the most common cancerous brain tumor of childhood, and a major cause of death and disability in Canadian children. Current treatments are non-specific and consist of aggressive surgery, radiation to the whole brain and spinal cord foll
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Canada Research Chair - Tier 2
-
批准号:459661
-
项目类别:
-
资助金额:$43.71万
-
财政年份:2021
-
负责人:Ramaswamy Vijay
-
依托单位:
Molecular and Functional Characterization of Childhood Ependymoma
-
批准号:381502
-
项目类别:Operating Grants
-
资助金额:$66.6万
-
财政年份:2018
-
负责人:Ramaswamy Vijay
-
依托单位:
Molecular and Clinical Sub-classification of the WNT Subgroup of Medulloblastoma
-
批准号:230248
-
项目类别:Fellowship Programs
-
资助金额:$13.11万
-
财政年份:2011
-
负责人:Ramaswamy Vijay
-
依托单位:
海外基金